Lyka Labs Limited

Web: lykalabs.com NSE: LYKALABS BSE: 500259 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

75 1(1%)

Volume

20k as on 30, Jan

Open

74

High

74

Low

70

Close

74

VWAP

72

52 Week High

121

52 Week Low

44

Viand Research Rating
Quality Score

0/100

Growth Score

17/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

267

No. of Shares

3.57

P/E

140.62

P/B

5.62

Face Value

10

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

3.99

ROCE

-

Profit Growth

-

Listing Date

08-Feb-95

Promoter Holding

58.16%

FII Holding

0.29%

DII Holding

0.66%

Price Chart
Price Performance
1 Week2%
1 Month6%
3 Months24%
6 Months37%
1 Year52%
YTD7%
Moving Average
5 Day SMA73
10 Day SMA74
20 Day SMA77
30 Day SMA76
50 Day SMA78
61 Day SMA80
80 Day SMA84
200 Day SMA99
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 377747677
Resistance 276747576
Resistance 175747575
Pivot Point74737474
Support 173737373
Support 272737372
Support 371737271
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,68,09919510%4%19%16%3757.70.0711509
2DIVISLAB1,93,79273002%9%22%11%6957.702568
3TORNTPHARM1,70,90750500%13%25%42%7257.71.792138
4APOLLOHOSP1,27,26488510%6%31%21%5857.70.92003
5CIPLA1,12,69413952%0%3%4%2257.70.023862
6ZYDUSLIFE1,10,62311093%4%27%17%2057.70.465124
7LUPIN1,09,68623993%3%11%25%2357.70.295355
8MANKIND1,05,60325570%0%18%3%4957.70.391938
9MAXHEALTH1,05,11410802%1%8%14%057.70.321442
10DRREDDY97,63811704%8%3%5%2057.70.24158
Load More
Shareholding Pattern (%)
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 58.16%(0.01) 58.16%(0.01) 58.16%(0.01) 58.16%(0.01) 58.16%(0.01) 58.11%(0.01) 58.11%(3.31) 58.11%(0.01) 54.81%(0.01) 54.81%(0.21) 54.81%(3.61) 54.58%(3.41) 51.00%(0.01) 47.58%(-0.21) 47.58%(0.01) 47.80%(27.81) 47.79%(0.01) 20.04%(0.01) 20.00%
FIIs(0.11) 0.29%(0.01) 0.17%(0.01) 0.17%(-0.11) 0.16%(0.11) 0.24%(0.01) 0.15%(0.01) 0.15%(0.01) 0.15%(0.01) 0.17%(0.01) 0.17%(0.01) 0.18%(0.01) 0.17%(-0.21) 0.18%(-0.21) 0.37%(-0.21) 0.57%(-0.41) 0.76%(0.01) 1.12%(-0.91) 1.13%(0.01) 2.07%
DIIs(0.01) 0.66%(0.01) 0.66%(0.01) 0.66%(0.01) 0.66%(0.01) 0.66%(0.01) 0.66%(-0.11) 0.66%(-0.11) 0.75%(0.21) 0.81%(0.21) 0.62%(0.01) 0.41%(-3.31) 0.41%(-0.31) 3.74%(0.01) 4.00%(0.01) 4.00%(2.81) 3.99%(0.71) 1.19%(-1.41) 0.47%(0.01) 1.85%
Public40.89%40.99%40.99%41.02%40.93%41.07%41.08%40.99%44.21%44.41%44.61%44.84%45.08%48.05%47.85%47.45%49.89%78.36%76.08%
No. of Shareholders26,72727,15527,74328,18928,47229,09928,94325,71625,71726,42226,65227,20226,82028,51528,43326,96926,22027,72020,672
Quarterly Results
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
Sales28.0330.7336.6633.0333.4333.841.1630.1127.7732.5627.9922.8822.2417.8225.5327.4935.1935.5773.8949.44
Sales Growth % (YoY)-16.2%-9.1%-10.9%9.7%20.4%3.8%47%31.6%24.9%82.7%9.6%-16.8%-36.8%-49.9%-65.4%-44.4%45%32.7%323.2%179%
Sales Growth % (QoQ)-8.8%-16.2%11%-1.2%-1.1%-17.9%36.7%8.4%-14.7%16.3%22.3%2.9%24.8%-30.2%-7.1%-21.9%-1.1%-51.9%49.5%-
Expenses34.4829.0839.229.3529.3528.6136.2126.425.7525.6923.8220.2418.9415.6120.521.1822.5922.5528.2719.54
Operating Profit-6.451.65-2.543.684.085.194.953.712.026.874.172.643.32.215.036.3112.613.0245.6229.9
OPM %-23.015.37-6.9311.1412.215.3612.0312.327.2721.114.911.5414.8412.419.722.9535.8136.661.7460.48
Other Income0.611.161.090.630.820.830.030.560.320.54-0.180.380.02-5.950.980.95-2.270.58-3.20.47
Interest0.70.820.790.850.470.610.540.651.071.281.191.352.853.083.032.912.994.645.576.93
Depreciation2.042.152.152.111.421.831.761.762.92.843.593.473.473.473.623.599.462.243.522.13
Profit before tax-8.58-0.16-4.391.353.013.582.681.86-1.633.29-0.79-1.8-3-10.29-0.640.76-2.126.7233.3321.31
Tax %-6.06-6.25-26.6526.6732.8924.328.3630.6528.2238.6-22.787.2202.24-46.886.58607.086.5516.988.59
Net Profit -8.07-0.15-3.220.992.032.71.911.29-2.091.78-0.49-1.85-3.01-10.42-0.380.6-15.076.0928.4319.55
Net Profit Growth % (QoQ)-5280%95.3%-425.3%-51.2%-24.8%41.4%48.1%161.7%-217.4%463.3%73.5%38.5%71.1%-2642.1%-163.3%104%-347.5%-78.6%45.4%-
Net Profit Growth % (YoY)-497.5%-105.6%-268.6%-23.3%197.1%51.7%489.8%169.7%30.6%117.1%-28.9%-408.3%80%-271.1%-101.3%-96.9%----
TTM Net Profit-10.45-0.352.57.637.933.812.890.49-2.65-3.57-15.77-15.66-13.21-25.27-8.7620.053954.0747.980
EPS in Rs-2.130-0.940.260.50.760.590.4-0.630.54-0.15-0.56-0.98-3.63-0.130.21-5.252.129.916.81
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Jun 2015Jun 2014Mar 2013Jan 1900
Sales1281381119319486617160110130166119127130
Sales Growth %-7.3%24.6%19.5%-52%125%40.3%-13.1%18.3%-45.7%-15.6%9.7%39.9%-6.5%-25.1%-
Expenses132121957693676573638711013911199110
Operating Profit-418161710120-4-2-423202882820
OPM %-31314185223-6-3-621161772216
Other Income421-4-40-3014-2842538
Interest32512202620710191524271915
Depreciation8713141788711109119129
Profit before tax-1211-1-1359-14-62-15-20-84-3-304
Tax %-1129182035-291-59-5-19-531450-5
Net Profit -108-3-1338-10-63-6-19-74-5-5-14
Net Profit Growth %-225%366.7%76.9%-134.2%480%84.1%-950%68.4%-171.4%-275%180%--400%-125%-
EPS in Rs-2.812.24-0.75-4.313.59-4.03-21.1-1.97-6.14-2.511.67-2.29-3.05-0.331.67
Dividend Payout %000000000000000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Jun 2015Jun 2014Mar 2013
Cash from Operating Activity5229799527113112278911
Cash from Investing Activity-9-12-97-600-4-3-131737-575
Cash from Financing Activity452-22-63-123-23-10-19-30-60-26-13
Net Cash Flow0-5-6-510-39-1-30-1463
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Jun 2015Jun 2014Mar 2013
Equity Capital36363636333129292928282222222222
Reserves576568633515-15-54-4315211622203044
Borrowings49323935597513016314196113126121137164127
Other Liabilities3335333430314252737667887710011396
Total Liabilities175168176168157152186190200216229252242279329289
Fixed Assets878785585868949810510811613310412216293
CWIP21128231618262831282430272247
Investments0000000000000006
Other Assets868090837667746668778594107130145143
Total Assets175168176168157152186190200216229252242279329289
Delivery
#Date
55
41%
77
Value (Cr)Q/T
159
Del
62
Del
1
11-Jul75
1
76620
230-Jun74
0
28350
329-Jun73
0
63710
425-Jun70
0
61670
524-Jun70
0
69650
623-Jun67
0
63540
722-Jun68
0
58630
819-Jun67
0
71810
918-Jun70
0
60560
1017-Jun71
0
65570
1116-Jun69
1
100440
1215-Jun72
0
92710
1312-Jun70
0
66660
1411-Jun69
1
86570
1510-Jun72
3
137501
169-Jun70
2
131681
178-Jun64
1
115691
185-Jun64
1
171721
194-Jun60
1
295891
203-Jun57
0
81660
212-Jun58
0
68630
221-Jun57
0
57600
2329-May58
0
111810
2427-May58
0
79620
2526-May60
1
84731
2625-May62
0
63650
2722-May61
0
55720
2821-May61
0
23800
2920-May61
0
135500
3019-May60
0
77800
Daily Market Cap
DateTotal Market CapChangeChg %
01-Jul268c7c2.67
30-Jun261c5c1.98
29-Jun256c1c0.46
26-Jun254c89L0.35
25-Jun255c6c2.42
24-Jun249c12c4.90
23-Jun238c6c2.28
22-Jun243c89L0.37
19-Jun242c6c2.30
18-Jun248c2c0.80
17-Jun250c4c1.74
16-Jun246c11c4.42
15-Jun257c7c2.84
12-Jun250c13c4.83
11-Jun263c5c1.93
10-Jun268c00
Stock Checklist
Price is below from 52 week high low average: 20%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: NO
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
0